Lyon Joseph Douglas: insider trades.
Lyon Joseph Douglas reported 8 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($1.3M), across 1 company.
- Transactions
- 8
- Purchases (P)
- 0
- Sales (S)
- 3
- Companies
- 1
- Name as filed
- Lyon Joseph Douglas
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Corcept Therapeutics Inc (CORT) | Officer · See Remarks | 8 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-14 | Corcept Therapeutics Inc | M | 2,596 | $11.35 | 8,279 | Form 4 |
| 2026-09-14 | Corcept Therapeutics Inc | S | 7,812 | $113.32 | 7,871 | Form 4 |
| 2026-09-14 | Corcept Therapeutics Inc | M | 7,404 | $13.56 | 15,683 | Form 4 |
| 2026-09-14 | Corcept Therapeutics Inc | S | 2,188 | $114.12 | 5,683 | Form 4 |
| 2026-09-02 | Corcept Therapeutics Inc | F | 72 | $113.38 | 5,683 | Form 4 |
| 2026-09-01 | Corcept Therapeutics Inc | A | 130 | $0 | 5,755 | Form 4 |
| 2026-09-01 | Corcept Therapeutics Inc | A | 130 | $113.38 | 5,625 | Form 4 |
| 2026-08-03 | Corcept Therapeutics Inc | S | 1,540 | $114.16 | 5,495 | Form 4 |
Questions
What stock did Lyon Joseph Douglas buy or sell?
Lyon Joseph Douglas reported 8 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($1.3M), across 1 company.
Is Lyon Joseph Douglas the same person as other filers with this name?
This page covers SEC CIK 1817838 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/lyon-joseph-douglas-1817838.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.